SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2016(Abstract) Dolutegravir plus Rilpivirine in cART-Experienced Subjects: a cohort study | Dr. G. SterrantinoView Slideset
CFPCarlo Federico PernoMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2016HIV in Europe 2020 – what will it look like? | Carlo Federico Perno, MD, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2016(Abstract) Potent Activity of GS-9883, a Novel Unboosted HIV-1 Integrase Strand Transfer Inhibitor (INSTI), Against Patient Isolates with INSTI-Resistance | Dr. K. WhiteView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2016(Abstract) Ex vivo determination of stem cell transplantation graft-versus-HIV reservoir effects | Dr. L. HoganView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2016(Abstract) Breakthrough of preexisting X4-tropic HIV after allogeneic stem-cell transplantation | Dr. J. VerheyenView Slideset
JVJens VerheyenMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2016Improving PI drug resistance scores | Jens Verheyen, MD, PhDView Slideset
LVLinos VandekerckhoveMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2016PI remain important options for first line | Linos Vandekerckhove, MD, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2016HIV attachment Inhibitors - Educational lecture in collaboration with ESAR | Thomas Klimkait, MDView Slideset
CBCharles BoucherMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2016Maintenance Therapy - What is the scientific/ virological rational | Charles Boucher, MD, PhDView Slideset
PCPep CollMD, MSSlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2016Roadblocks to implementation | Pep Coll, MDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2016Community perspective | Rebekah WebbView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2016(Abstract) HBsAg immune-escape Mutations and Stop-Codons, Circulating among European HBV-chronically infected patients can impact on HBV transmission and disease progression | Dr. L. ColagrossiView Slideset
